Will GoI have Rs 80,000 cr for Covid19 vaccination drive? asks Serum’s Poonawalla
Team Udayavani, Sep 26, 2020, 6:08 PM IST
New Delhi: Adar Poonawalla, the CEO of the Serum Institute of India on Saturday said that the drive to vaccinate all Indians against the COVID pandemic will cost around Rs 80,000 crore.
Taking to Twitter, Poonawalla sought to know if the government has enough resources to fund the huge vaccination drive to eradicate the pandemic.
“Quick question; will the government of India have 80,000 crores available, over the next one year? Because that’s what @MoHFW_INDIA needs, to buy and distribute the vaccine to everyone in India. This is the next concerning challenge we need to tackle. @PMOIndia,” Poonawalla tweeted.
“I ask this question, because we need to plan and guide, vaccine manufacturers both in India and overseas to service the needs of our country in terms of procurement and distribution,” he added.
The SII has partnered with British-Swedish pharma company AstraZeneca, US drug developer Novavax Inc and three other firms for manufacturing the COVID-19 vaccine candidate.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Kejriwal promises to waive inflated water, electricity bills if AAP returns to power in Delhi
Jaishankar to visit Australia, Singapore from Nov 3-8
Kodakara black money case: BJP should change party symbol to sack, says CPI(M)
Congress calls for probe over BJP’s ‘use of blackmail’ to bring Ajit Pawar into NDA fold
PM Modi, Greece counterpart review progress in bilateral ties
MUST WATCH
Latest Additions
Kejriwal promises to waive inflated water, electricity bills if AAP returns to power in Delhi
Rohit Bal: The Valley boy who strode to great heights in fashion
Jaishankar to visit Australia, Singapore from Nov 3-8
Kadaba: Scooter rider’s death in tree fall – Public protests, demands removal of hazardous trees
Bantwal: Old video of elderly woman bursting firecrackers in hand goes viral
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.